Siemens Healthineers stock: RBC raises target from EUR 45.00 to EUR 48.00
Published on 10/23/2026 at 16:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- RBC raised its target from EUR 45.00 to EUR 48.00 on October 16, 2026.
- Siemens Healthineers scheduled its fourth-quarter results for November 5, 2026.
- Siemens Healthineers stock costs EUR 41.74 at Lang & Schwarz on October 23, 2026 at 4:39 p.m. CEST, minus 0.05 percent versus the Xetra close of October 22, 2026, 13.04 percent below the 52-week high.
Siemens Healthineers (ISIN DE000SHL1006) received a higher RBC target of EUR 48.00, up from EUR 45.00, in a note dated October 16, 2026. According to MarketScreener, RBC kept its Outperform rating. Siemens Healthineers stock was trading at EUR 41.74 at Lang & Schwarz on October 23, 2026 at 4:39 p.m. CEST, down EUR 0.02 or 0.05 percent versus the Xetra close of October 22, 2026.
RBC target leaves 15.00 percent upside
The new RBC target lies 15.00 percent above the Lang & Schwarz price. The research note linked the view to the launch of Accela, a radiation therapy system, and described the product as evidence of the companys clinical capabilities.
Stock stays below its yearly high
The stock stood 13.04 percent below its 52-week high of EUR 49.71 and 27.22 percent above its 52-week low of EUR 32.81 on October 23, 2026. The same quote showed a market capitalization of EUR 46.6 billion, a price-earnings ratio of 21.06 and volume of 606,036 shares.
November 5 is the next reporting date
Siemens Healthineers scheduled its fourth-quarter results and analyst call for November 5, 2026. The companys investor-relations page also identifies the latest reported period as third-quarter results dated July 31, 2026, linking the next update to a defined reporting timetable.
What does the target imply?
RBCs move from EUR 45.00 to EUR 48.00 represents a 6.67 percent increase in the target. That target sits EUR 6.26 above the current euro quote, while the shares remain EUR 7.97 below the 52-week high.
Price and dates
The immediate stock picture is restrained: Siemens Healthineers was down 0.05 percent against the October 22, 2026 Xetra close, while the next scheduled corporate date is November 5, 2026.
Stock position after RBC update
Siemens Healthineers stock was trading at EUR 41.74 at Lang & Schwarz on October 23, 2026 at 4:39 p.m. CEST, 0.05 percent below the Xetra close of October 22, 2026 at EUR 41.76. The 52-week range was EUR 32.81 to EUR 49.71.
The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.
Siemens Healthineers stock at a glance
- Company: Siemens Healthineers AG
- ISIN: DE000SHL1006
- WKN: SHL100
- Ticker: SHL
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 23, 2026, 4:39 p.m. CEST): EUR 41.74
- Change versus Xetra close: minus 0.05 percent
- Xetra close (October 22, 2026): EUR 41.76
- Market capitalization: EUR 46.6 billion (as of October 23, 2026)
- 52-week range: EUR 32.81-EUR 49.71 (as of October 23, 2026)
- Sector / Industry: Health Care / Advanced Medical Equipment and Technology
- Next earnings date: November 5, 2026
Market context: Market report DAX.
